Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Quality of Life of Tildrakizumab in Plaque Psoriasis
NCT03718299Phase 4Completed
- Sponsor
- Sun Pharma
- Start
- Jul 2019
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of tildrakizumab in plaque psoriasis, sponsored by Sun Pharma. Started Jul 2019; status: completed.
02
Drugs
tildrakizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03718299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03718299.